Sanofi has entered into a new collaboration agreement with DarioHealth, a leader in global digital therapeutics. This collaboration will help advance Sanofi’s mission of reversing the course of chronic diseases such as diabetes through the integration of healthcare and technology.
Through this partnership, Sanofi will co-promote Dario technology solutions and help expand access to Dario solutions through Insurance plans and employers for people living with diabetes and other conditions such as hypertension, musculoskeletal pain, and behavioral health.
To read the full press release, click here.
Sanofi is a 2022 National Strategic Partner of DiabetesSisters. DiabetesSisters shares information they provide that is useful to our community; however, the relationship does not influence the decisions or opinions of DiabetesSisters, its governing board or staff.